Potential therapeutics for obesity and atherosclerosis: Inhibitors of neutral lipid metabolism from microorganisms

Pharmacology and Therapeutics

Volumn 115, Issue 3, 2007, Pages 375-389

  Tomoda, Hiroshi ^a   Omura, Satoshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

ACAT; Acyl CoA; Acyltransferase; Cholesterol; DGAT; Diacylglycerol; Isozymes; Microbial inhibitor

Indexed keywords

ACYLTRANSFERASE INHIBITOR; AMIDEPSINE A; AMIDEPSINE B; AMIDEPSINE C; AMIDEPSINE D; AMIDEPSINE E; AVASIMIBE; BEAUVERIOLIDE DERIVATIVE; BEAUVERIOLIDE III; CHOLESTEROL ACYLTRANSFERASE; CL 283546; DIACYLGLYCEROL ACYLTRANSFERASE; GLISOPRENIN B; ISOBISVERTINOL; K 97 0239A; K 97 0239B; PACTIMIBE; PHENOCHALASIN B; PURPACTIN A; PURPACTIN B; PURPACTIN C; PYRIPYROPENE A; PYRIPYROPENE DERIVATIVE; ROSELIPIN 1A; ROSELIPIN 1B; ROSELIPIN 2A; ROSELIPIN 2B; SPYLIDONE; TERPENDOLE C; UNCLASSIFIED DRUG; UNINDEXED DRUG; WU V 23; XANTHOHUMOL; XANTHOHUMOL B;

ACTINOBACTERIA; ANIMAL CELL; ATHEROSCLEROSIS; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DRUG SCREENING; DRUG SELECTIVITY; FUNGAL STRAIN; LIPID METABOLISM; LIVER MICROSOME; MACROPHAGE; MICROORGANISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REVIEW;

ACTINOBACTERIA; ANIMALS; ATHEROSCLEROSIS; DIACYLGLYCEROL O-ACYLTRANSFERASE; DRUG DELIVERY SYSTEMS; FUNGI; HUMANS; LIPID METABOLISM; OBESITY; PLANT EXTRACTS; PLANTS, MEDICINAL; STEROL O-ACYLTRANSFERASE;

EID: 34548447685     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.05.008     Document Type: Review

References (95)

1. Anderson R.A., Joyce C., Davis M., Reagan J.W., Clark M., Shelness G.S., et al. Identification of a form of acyl-CoA: cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem 273 (1998) 26747-26754
2. Audhya T.K., and Russell D.W. Production of enniatins by Fusarium sambucinum: Selection of high-yield conditions from liquid surface cultures. J Gen Microbiol 82 (1974) 181-190
3. Bell R.M., and Coleman R.A. Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem 49 (1980) 459-487
4. Brown M.S., Goldstein J.L., Krieger M., Ho Y.K., and Anderson R.G.W. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J Cell Biol 82 (1979) 597-613
5. Buhman K.K., Accad M., Novak S., Choi R.S., Wong J.S., Hamilton R.L., et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 6 (2000) 1341-1347
6. Casaschi A., Rubio B.K., Maiyoh G.K., and Theriault A.G. Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion. Atherosclerosis 176 (2004) 247-253
7. Cases S., Smith S.J., Zheng Y.-W., Myers H.M., Lear S.R., Sande E., et al. Identification of a gene encoding an acyl CoA: diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A 95 (1998) 13018-13023
8. Cases S., Novak S., Zheng Y.-W., Myers H.M., Lear S.R., Sande E., et al. ACAT-2, a second mammalian acyl-CoA: cholesterol acyltransferase. Its cloning, expression, and characterization. J Biol Chem 273 (1998) 26755-26764
9. Cases S., Stone S.J., Zhou P., Yen E., Tow B., Lardizabal K.D., et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 276 (2001) 38870-38876
10. Chang C.C., Huh H.Y., Cadigan K.M., and Chang T.Y. Molecular cloning and functional expression of human acyl-coenzyme A: cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J Biol Chem 268 (1993) 20747-20755
11. Chen H.C., and Farese Jr. R.V. DGAT and triglyceride synthesis: a new target for obesity treatment?. Trends Cardiovasc Med 10 (2000) 188-192
12. Chen H.C., and Farese Jr. R.V. Inhibition of triglyceride synthesis as a treatment strategy for obesity. Arterioscler Thromb Vasc Biol 25 (2005) 482-486
13. Chen H.C., Smith S.J., Ladha Z., Jensen D.R., Ferreira L.D., Pulawa L.K., et al. Increased insulin and leptin sensitivity in mice lacking acyl-CoA: diacylglycerol acyltransferase 1. J Clin Invest 109 (2002) 1049-1055
14. Cho K.H., An S., Lee W.S., Paik Y.K., Kim Y.K., and Jeong T.S. Mass production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. Biochem Biophys Res Commun 309 (2003) 864-872
15. Deol B.D., Ridley D.D., and Singh P. Isolation of cyclodepsipeptides from plant pathogenic fungi. Aust J Chem 31 (1974) 1397-1399
16. Elix J.A., Jayanthi V.K., and Leznoff C.C. 2,4-Di-O-methylgyrophoric acid and 2,4,5-tri-O-methylhiascic acid. New tridepsides from Parmelia damaziana. Aust J Chem 34 (1981) 1757-1761
17. Fazio S., and Linton M. Failure of ACAT inhibition to retard atherosclerosis. N Engl J Med 354 (2006) 1037-1039
18. Farese Jr. R.V. Acyl CoA: cholesterol acyltransferase genes and knockout mice. Curr Opin Lipidol 9 (1998) 119-123
19. Gatenby W.A., Munday-Finch S.C., Wilkins A.L., and Miles C.O. Terpendole M, a novel indole-diterpenoid isolated from Lolium perenne infected with the endophytic fungus Neotyphodium lolii. J Agric Food Chem 47 (1999) 1092-1097
20. Gerrity R.G. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103 (1981) 181-190
21. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76 (1979) 333-337
22. Guo Z.-Y., Lin S., Heinen J.A., Chang C.C., and Chang T.-Y. The active site His-460 of human acyl-coenzyme A: cholesterol acyltransferase 1 resides in a hitherto undisclosed transmembrane domain. J Biol Chem 280 (2005) 37814-37826
23. Hamill R.L., Higgens C.E., Boaz H.E., and Gorman M. The structure of beauvericin, a new depsipeptide antibiotic toxic to Artemia salina image. Tetrahedron Lett 49 (1969) 4255-4258
24. Huang X.H., Nishida H., Tomoda H., Tabata N., Shiomi K., Yang D.J., et al. Terpendoles, novel ACAT inhibitors produced by Albophoma yamanashiensis. II. Structure elucidation of terpendoles A, B, C and D. J Antibiot 48 (1995) 5-11
25. Joyce C.W., Shelness G.S., Davis M.A., Lee R.G., Skinner K., Anderson R.A., et al. ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. Mol Biol Cell 11 (2000) 3675-3687
26. Kathawala F.G., and Heider J.C. In antilipidemic drugs. In: Witiak D.T., Newman H.A.I., and Feller D.R. (Eds) (1992), Elsevier, New York 159-195
27. Kim Y.K., Tomoda H., Nishida H., Sunazuka T., Obata R., and Ōmura S. Pyripyropenes, novel inhibitors of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus. II. Structure elucidation of pyripyropenes A, B, C and D. J Antibiot 47 (1994) 154-162
28. Ko J.S., Ko J.S., Ryu S.Y., Kim Y.S., Chung M.Y., Kang J.S., et al. Inhibitory activity of diacylglycerol acyltransferase by tanshinones from the root of Salvia miltiorrhiza. Arch Pharm Res 25 (2002) 446-448
29. Kobayashi T., Masuma R., Ōmura S., and Watanabe K. Materials for the fungus flora of Japan (47). Mycoscience 35 (1994) 399-401
30. Koyama N., Nagahiro T., Yamaguchi Y., Ohshiro T., Masuma R., Tomoda H., et al. Spylidone, a novel inhibitor of lipid droplet accumulation in mouse macrophages produced by Phoma sp. FKI-1840. J Antibiot 58 (2005) 338-345
31. Koyama N., Ohshiro T., Tomoda H., and Ōmura S. Fungal isobisvertinol, a new inhibitor of lipid droplet accumulation in mouse macrophages. Org Lett 9 (2007) 425-428
32. Lada A.T., Davis M., Kent C., Chapman J., Tomoda H., Ōmura S., et al. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. J Lipid Res 45 (2004) 378-386
33. Lardizabal K.D., Mai J.T., Wagner N.W., Wyrick A., Voelker T., and Hawkins D.J. DGAT2 is a new diacylglycerol acyltransferase gene family: purification, cloning, and expression in insect cells of two polypeptides from Mortierella ramanniana with diacylglycerol acyltransferase activity. J Biol Chem 276 (2001) 38862-38869
34. Lee S.W., Kim K., Rho M.C., Chung M.Y., Kim Y.H., Lee S., et al. New polyacetylenes, DGAT inhibitors from the roots of Panax ginseng. Planta Medica 70 (2004) 197-200
35. Lehner R., and Kuksis A. Biosynthesis of triacylglycerols. Prog Lipid Res 35 (1996) 169-201
36. Lin S., Cheng D., Liu M.-S., Chen J., and Chang T.-Y. Human acyl-CoA: cholesterol acyltransferase-1 in the endoplasmic reticulum contains seven transmembrane domains. Human acyl-CoA: cholesterol acyltransferase-1 in the endoplasmic reticulum contains seven transmembrane domains. J Biol Chem 274 (1999) 23276-23285
37. Matsuda D., Namatame I., Tomoda H., Kobayashi S., Zocher R., Kleinkauf H., et al. New beauveriolides produced by amino acid-supplemented fermentation of Beauveria sp. FO-6979. J Antibiot 57 (2004) 1-9
38. Mayorek N., and Bar-Tana J. Inhibition of diacylglycerol acyltransferase by 2-bromooctanoate in cultured rat hepatocytes. J Biol Chem 260 (1985) 6528-6532
39. Meiner V.L., Cases S., Myers H.M., Sande E.R., Bellosta S., Schambelan M., et al. Disruption of the acyl-CoA: cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A 93 (1996) 14041-14046
40. Miyazaki A., Kanome T., and Watanabe T. Inhibitors of acyl-coenzyme A: cholesterol acyltransferase. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 463-469
41. Mochizuki K., Omori K., Tamura H., Shizuri Y., Nishiyama S., Miyoshi E., et al. The structures of bioactive cyclodepsipeptides, beauveriolides I and II, metabolites of entomopathogenic fungi Beauveria sp. Bull Chem Soc Jpn 66 (1993) 3041-3046
42. Nagai K., Doi T., Sekiguchi T., Namatame I., Sunazuka T., Tomoda H., et al. Synthesis and biological evaluation of a beauveriolide analogue library. J Comb Chem 8 (2006) 103-109
43. Namatame I., Tomoda H., Arai H., Inoue K., and Ōmura S. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C. J Biochem 125 (1999) 319-327
44. Namatame I., Tomoda H., Si S., Yamaguchi Y., Masuma R., and Ōmura S. Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FO-6979. J Antibiot 52 (1999) 1-6
45. Namatame I., Tomoda H., Tabata N., Si S., and Ōmura S. Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages. J Antibiot 52 (1999) 7-12
46. Namatame I., Tomoda H., Arai M., and Ōmura S. Effect of fungal metabolites cytochalasans on lipid droplet formation in mouse macrophages. J Antibiot 53 (2000) 19-25
47. Namatame I., Tomoda H., Matsuda D., Tabata N., Kobayashi S., and Ōmura S. K97-0239A and B, inhibitors of macrophage foam cell formation, produced by Streptomyces sp. K97-0239. Proc Jpn Acad 78 (2002) 45-50
48. Namatame I., Tomoda H., Ishibashi S., and Ōmura S. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. Proc Natl Acad Sci U S A 101 (2004) 737-742
49. Nicolaou K.C., Xiao X.-Y., Parandoosh Z., Senyei A., and Nova M.P. Radiofrequency encoded combinatorial chemistry. Angew Chem Int Ed Engl 34 (1995) 2289-2291
50. Nicolaou K.C., Pfefferkorn J.A., Mitchell H.J., Roecker A.J., Barluenga S., Cao G.-Q., et al. Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split- and-pool chemistry using NanoKans and Optical Encoding. J Am Chem Soc 122 (2000) 9954-9967
51. Nishida H., Tomoda H., Cao J., Okuda S., and Ōmura S. Purpactins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Penicillium purpurogenum. II. Structure elucidation of purpactins A, B and C. J Antibiot 44 (1991) 144-151
52. Nishida H., Huang X.H., Tomoda H., and Ōmura S. Glisoprenins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Gliocladium sp. FO-1513. II. Structure elucidation of glisoprenins A and B. J Antibiot 45 (1992) 1669-1676
53. Nishikawa K., Arai H., and Inoue K. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J Biol Chem 265 (1990) 5226-5231
54. Nissen S.E., Tuzcu E.M., Brewer H.B., Sipahi I., Nicholls S.J., Ganz P., et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 354 (2006) 1253-1263
55. Obata R., Sunazuka T., Li Z., Tomoda H., and Ōmura S. Structure-activity relationships of pyripyropenes, fungal acyl-CoA: cholesterol acyltransferase inhibitors. J Antibiot 48 (1995) 749-750
56. Obata R., Sunazuka T., Tomoda H., Harigaya Y., and Ōmura S. Chemical modification and structure-activity relationships of pyripyropenes; potent, bioavailable inhibitor of acyl-CoA: cholesterol acyltransferase (ACAT). Bioorg Med Chem Lett 5 (1995) 2683-2688
57. Obata R., Sunazuka T., Li Z., Tian Z., Harigaya Y., Tabata N., et al. Chemical modification and structure-activity relationships of pyripyropenes. 1. Modification at the four hydroxy groups. J Antibiot 49 (1996) 1133-1148
58. Obata R., Sunazuka T., Kato Y., Tomoda H., Harigaya Y., and Ōmura S. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1, 11-Cyclic analogs. J Antibiot 49 (1996) 1149-1156
59. Obata R., Sunazuka T., Tian Z., Tomoda H., Harigaya Y., and Ōmura S. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety. J Antibiot 50 (1997) 229-236
60. Obata R., Sunazuka T., Tian Z., Tomoda H., Harigaya Y., Ōmura S., et al. New analogs of the pyripyropene family of ACAT inhibitors Via α-pyrone fragmentation and d acylation/cyclization. Chem Lett (1997) 935-936
61. Oelkers P., Behari A., Cromley D., Billheimer J.T., and Sturley S.L. Characterization of two human genes encoding acyl coenzyme A: cholesterol acyltransferase-related enzymes. J Biol Chem 273 (1998) 26765-26771
62. Ohshiro T., Namatame I., Nagai K., Sekiguchi T., Doi T., Takahashi T., et al. Absolute stereochemistry of fungal beauveriolide III and ACAT inhibitory activity of four stereoisomers. J Org Chem 71 (2006) 7643-7649
63. Ohshiro T., Rudel L.L., Ōmura S., and Tomoda H. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes. J Antibiot 60 (2007) 43-51
64. Ōmura S., Tomoda H., Kim Y.K., and Nishida H. Pyripyropenes, highly potent inhibitors of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus. J Antibiot 46 (1993) 1168-1169
65. Ōmura S., Tomoda H., Tabata N., Ohyama Y., Abe T., and Namikoshi M. Roselipins, novel fungal metabolites having a highly methylated fatty acid modified with a mannose and an arabinitol. J Antibiot 52 (1999) 586-589
66. Parini P., Davis M., Lada A.T., Erickson S.K., Wright T.L., Gustafsson U., et al. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation 110 (2004) 2017-2023
67. Reindel J.F., Dominick M.A., Bocan T.M., Gough A.W., and McGuire E.J. Toxicologic effects of a novel acyl-CoA: cholesterol acyltransferase inhibitor in cynomolgus monkeys. Toxicol Pathol 22 (1994) 510-518
68. Sliskovic D.R., and Trivedi B.K. ACAT inhibitors: potential anti-atherosclerotic agents. Curr Med Chem 1 (1994) 204-225
69. Sliskovic D.R., and White A.D. Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents. Trends Pharmacol Sci 12 (1991) 194-199
70. Sliskovic D.R., Picard J.A., O'Brien P.M., Liao P., Roark W.H., Roth B.D., et al. Alpha-substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicity. J Med Chem 41 (1998) 682-690
71. Smith S.J., Cases S., Jensen D.R., Chen H.C., Sande E., Tow B., et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking DGAT. Nat Genet 25 (2000) 87-90
72. Stone S.J., Myers H.M., Watkins S.M., Brown B.E., Feingold K.R., Elias P.M., et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 279 (2004) 11767-11776
73. Stone S.J., Levin M.C., and Farese Jr. R.V. Membrane topology and identification of key functional amino acid residues of murine acyl-CoA: diacylglycerol acyltransferase-2. J Biol Chem 281 (2006) 40273-40282
74. Tabas I., Zha X., Beatini N., Myers J.N., and Maxfield F.R. The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages. J Biol Chem 269 (1994) 22547-22556
75. Tabata N., Ito M., Tomoda H., and Ōmura S. Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry 46 (1997) 683-687
76. Tabata N., Ohyama Y., Tomoda H., Abe T., Namikoshi M., and Ōmura S. Structure elucidation of roselipins, inhibitors of diacylglycerol acyltransferase produced by Gliocladium roseum KF-1040. J Antibiot 52 (1999) 815-826
77. Tanaka A., Terasawa T., Hagihara H., Sakuma Y., Ishibe N., Sawada M., et al. Inhibitors of acyl-CoA: cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N′-arylureas. J Med Chem 41 (1998) 2390-2410
78. Tardif J.C., Gregoire J., L'Allier P.L., Anderson T.J., Bertrand O., Reeves F., et al. Effects of the acyl coenzyme A: cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110 (2004) 3372-3377
79. Tomoda H., Igarashi K., Cyong J.-C., and Ōmura S. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation. J Biol Chem 266 (1991) 4214-4219
80. Tomoda H., Nishida H., Masuma R., Cao J., Okuda S., and Ōmura S. Purpactins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Penicillium purpurogenum. I. Production, isolation and physico-chemical and biological properties. J Antibiot 44 (1991) 136-143
81. Tomoda H., Nishida H., Huang X.H., Masuma R., Kim Y.K., and Ōmura S. New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305. J Antibiot 45 (1992) 1207-1215
82. Tomoda H., Huang X.H., Cao J., Nishida H., Nagao R., Okuda S., et al. Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics. J Antibiot 45 (1992) 1626-1632
83. Tomoda H., Huang X.H., Nishida H., Masuma R., Kim Y.K., and Ōmura S. Glisoprenins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Gliocladium sp. FO-1513. I. Production, isolation and physico-chemical and biological properties. J Antibiot 45 (1992) 1202-1206
84. Tomoda H., Kim Y.K., Nishida H., Masuma R., and Ōmura S. Pyripyropenes, novel inhibitors of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus. I. Production, isolation, and biological properties. J Antibiot 47 (1994) 148-153
85. Tomoda H., Nishida H., Kim Y.-K., Obata R., Sunazuka T., and Ōmura S. Relative and absolute stereochemistry of pyripyropene A, a potent, bioavailable inhibitor of acyl-CoA: cholesterol acyltransferase (ACAT). J Am Chem Soc 116 (1994) 12097-12098
86. Tomoda H., Ito M., Tabata N., Masuma R., Yamaguchi Y., and Ōmura S. Amidepsines, inhibitors of diacylglycerol acyltransferase produced by Humicola sp. FO-2942. I. Production, isolation and biological properties. J Antibiot 48 (1995) 937-941
87. Tomoda H., Tabata N., Ito M., and Ōmura S. Amidepsines, inhibitors of diacyl glycerol acyltransferase produced by Humicola sp. FO-2942. II. Structure elucidati on of amidepsines A, B and C. J Antibiot 48 (1995) 942-947
88. Tomoda H., Tabata N., Yang D.-J., Takayanagi H., and Ōmura S. Terpendoles, novel ACAT inhibitors produced by Albophoma yamanashiensis. III. Production, isolation and structure elucidation of new components. J Antibiot 48 (1995) 793-804
89. Tomoda H., Tabata N., Yang D.J., Takayanagi H., Nishida H., Ōmura S., et al. Pyripyropenes, novel ACAT inhibitors produced by Aspergillus fumigatus. III. Structure elucidation of pyripyropenes E to L. J Antibiot 48 (1995) 495-503
90. Tomoda H., Yamaguchi Y., Tabata N., Kobayashi T., Masuma R., Tanaka H., et al. Amidepsine E, an inhibitor of diacylglycerol acyltransferase produced by Humicola sp. FO-5969. J Antibiot 49 (1996) 929-931
91. Tomoda H., Tabata N., Yang D.J., Namatame I., Tanaka H., and Ōmura S. Pyripyropenes, novel ACAT inhibitors produced by Aspergillus fumigatus. IV. Structure elucidation of pyripyropenes M to R. J Antibiot 49 (1996) 292-298
92. Tomoda H., Ohyama Y., Abe T., Tabata N., Namikoshi M., Yamaguchi Y., et al. Roselipins, inhibitors of diacylglycerol acyltransferase, produced by Gliocladium roseum KF-1040. J Antibiot 52 (1999) 689-694
93. Tomoda H., Namatame I., Si S., Kawaguchi K., Masuma R., Namikoshi M., et al. Phenochalasins, inhibitors of lipid droplet formation in mouse macrophages, produced by Phomopsis sp. FT-0211. J Antibiot 52 (1999) 851-856
94. Tomoda H., Namatame I., Tabata N., Kawaguchi K., Si S., and Ōmura S. Structure elucidation of fungal phenochalasins, novel inhibitors of lipid droplet formation in mouse macrophages. J Antibiot 52 (1999) 857-861
95. Uchida R., Kim Y.-P., Namatame I., Tomoda H., and Ōmura S. Sespendole, a new inhibitor of lipid droplet synthesis in macrophages, produced by Pseudobotrytis terrestris FKA-25. J Antibiot 59 (2006) 93-97